Druggable Targets in Cytokine Release Syndromes.
Clin Cancer Res
; 29(21): 4320-4322, 2023 11 01.
Article
em En
| MEDLINE
| ID: mdl-37656058
ABSTRACT
Bispecific T-cell engagers and chimeric antigen receptor T cells share the problem of eliciting acute systemic inflammation episodes known as cytokine release syndrome. Knowledge on the sequential waves of cytokines that can be neutralized with clinically available agents is crucial to prevent or treat this condition without jeopardizing the antitumor therapeutic outcome. See related article by Leclercq-Cohen et al., p. 4449.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Anticorpos Biespecíficos
/
Síndrome da Liberação de Citocina
Limite:
Humans
Idioma:
En
Revista:
Clin Cancer Res
Ano de publicação:
2023
Tipo de documento:
Article